← FDA Drug Approvals (Drugs@FDA)
DALFAMPRIDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2016-07-19
Drug application
- FDA Application #
ANDA206854- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DALFAMPRIDINE
- Generic name
- Dalfampridine
- Active ingredients
- DALFAMPRIDINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2016-07-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown